Skip to NavigationSkip to content

eyeforpharma Oncology Market Access and Pricing

Thursday, June 15, 2017 - Friday, June 16, 2017
Le Meridien Philadelphia, 1421 Arch St
Philadelphia PA, United States

Event Type: Conference

Co-chaired by Aetna's Michael Kolodziej, the 2016 conference was seen as the most targeted and high-level gathering on commercialization of cancer products in the US. Join 150+ senior executives attended, including the following leading oncology innovators: Celgene;Eisai; Janssen; Novartis; BMS; Lilly; Genentech; Baxalta; GSK and Takeda. Here's why you should attend: Value-Based Pricing Metrics Round Robin - Hear why payers are hungry for these models, how they may leverage them, and which metrics will make a significant impact on the market access environment Determine How to Best Position Your Brand in an Evolving Market - Work cross-functionally with teams to address the challenges these metrics bring to develop a stronger market access trajectory by better demonstrating your products' importance. Prepare for Stakeholder's Demands - Adopt new business strategies that effectively generate, manage, and apply relevant health economic and clinical data from drug development through reimbursement Set Your Brand Apart in the Changing Payment Model Landscape - Decipher how potential APMs may impact your products and determine which are likely to have significant risks for the adoption of innovative drugs and biologics

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches